Hologic, Inc. (BIT:1HOLX)

Market Cap	11.79B
Revenue (ttm)	3.72B
Net Income (ttm)	513.95M
Shares Out	n/a
EPS (ttm)	2.21
PE Ratio	22.93
Forward PE	13.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	50.00
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
RSI	n/a
Earnings Date	Jul 30, 2025

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 1985
• Employees: 7,063
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1HOLX

Financial Performance

In 2024, Hologic's revenue was $4.03 billion, a decrease of -0.00% compared to the previous year's $4.03 billion. Earnings were $789.50 million, an increase of 73.14%.

Financial numbers in USD